Speaker Profile

MD, Medical Director, Biological Dynamics

Biography
Dr. Harmeet Dhani is the lead Medical Director at Biological Dynamics, a pioneering liquid biopsy biotechnology company focusing on extracellular vesicle-based biomarkers for early detection of cancer, and research in neurodegenerative and infectious diseases. He is also the Principal Investigator of the ExoLuminate clinical trial, aimed at early detection of high-risk pancreatic ductal adenocarcinoma (PDAC) patients. A surgeon scientist, Dr. Dhani completed a general surgery residency and specialized in transplant and hepatopancreatobiliary surgery, supplemented by a research fellowship at Georgetown University. His research, particularly in liver and intestinal diseases and transplantation, has earned him significant recognition, including the Emerging Liver Scholar Award and the Young Investigator Award from the American Transplant Congress. Dr. Dhani's career also includes valuable experience in the oncology division at Natera. He holds a Master's in Clinical Research from UCSD and is currently pursuing an Executive MBA at the UCSD Rady School of Management.


Talk
Exosomes Tell the Story
TBD


Clinical Dx Showcase:
Biological Dynamics

Biological Dynamics, Inc. is a San Diego biotechnology company committed to improving global health outcomes by detecting disease in its earliest stages. Our proprietary Verita™ platform simplifies access to biomarkers, enabling differentiated multiomic applications.

 Session Abstract – PMWC 2024 Silicon Valley

Showcase Track S2 - January 24 9.30 A.M.-1.45 P.M.,Showcase Track S2 - January 25 9.00 A.M.-4.15 P.M.,Showcase Track S2 - January 26 9.00 A.M.-2.45 P.M.


The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JUL. 18TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required